Martin Hutchings

Senior Consultant, Dept. of Haematology, Rigshospitalet

Copenhagen University Hospital

Denmark

Dr Martin Hutchings is a haemato-oncologist and a senior consultant from the Department of Haematology, Rigshospitalet, Copenhagen University Hospital and a professor of haematology at the University of Copenhagen. He is responsible for lymphoma treatment and clinical research and founded Denmark���s only dedicated Phase 1 unit for experimental treatment of haematological malignancies, which is a leading site for early development of lymphoma immunotherapy. After obtaining his medical degree and master���s degree (2000), he trained in nuclear medicine until pursuing his current specialisation in clinical oncology. In 2006, he defended his PhD on PET/CT in Hodgkin lymphoma. Dr Hutchings is an active member of various research groups, including the EORTC Lymphoma Group which he chaired from 2013 until 2017. He leads several clinical and translational studies in the field of lymphoma, with an emphasis on phase 1 haematology studies and on phase 2 and 3 Hodgkin lymphoma and mantle cell lymphoma, while maintaining a special scientific interest in the role of molecular imaging of malignant lymphoma. He is a prolific lecturer, educator, and research supervisor.